Possibility Related Posts:
Specialists have worked with 168 seniors, victims of some form of cognitive loss problem, as memory lapses or with language barriers, which go beyond the normal forgetfulness that everyone has. The researchers gave half the g
roup of volunteers high daily doses of vitamin B12, B6 and B9 (folic acid), while the rest received a placebo.
After two years the scans performed on patients who had received the cocktail of vitamin B showed that their brains had atrophied to 31% less than those of placebo recipients, in some cases, these percentages to 50%. Although the result is much more encouraging than the researchers of the project team Memory and Ageing (Optima) expected, they warn that it is only a first step and call for caution.
AMINO ACID REDUCER
New and more extensive tests should confirm the efficacy of vitamin B to reduce the levels of the amino acid in the blood, known as homocysteine, associated with brain atrophy and Alzheimer’s. In the study, people with higher homocysteine levels were those that were most benefited. “This vitamin is doing something in the structure of the brain, is protected and that is very important because we need to protect the brain to prevent Alzheimer’s,” says Professor David Smith, who acknowledges that the results are more significant than expected.
“The effect is much larger than anyone had predicted and we are stating that this is a biological effect,” he admits. “We hope he adds, that this simple treatment can delay the development of Alzheimer’s on many people who suffer a mild cognitive decline.”
CAUTION
Vitamin B is found naturally in foods such as meat, fish, eggs and vegetables. The researchers caution that no one should start taking vitamin B supplements in high doses without consulting your doctor. Doses above 200 milligrams per day of vitamin B6, for example, can lead to loss of feeling in arms and legs, although these symptoms are reversible after discontinuing the intake of vitamins. “We need further research before recommending vitamin B supplements as a treatment for neurodegenerative diseases,” says Chris Kennard, chairman of the Medical Research Council Neuroscience and Mental Health.
Poor training and 
